These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2110875)

  • 1. Effect of serum albumin on in vitro displacement of valproic acid by ceftriaxone and nafcillin.
    Dasgupta A; Dennen DA; Dean R
    Clin Chem; 1990 May; 36(5):825-6. PubMed ID: 2110875
    [No Abstract]   [Full Text] [Related]  

  • 2. Displacement of phenytoin from serum protein carriers by antibiotics: studies with ceftriaxone, nafcillin, and sulfamethoxazole.
    Dasgupta A; Dennen DA; Dean R; McLawhon RW
    Clin Chem; 1991 Jan; 37(1):98-100. PubMed ID: 1988217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Displacement effect of ceftriaxone on bilirubin bound to human serum albumin.
    Gulian JM; Dalmasso C; Pontier F; Gonard V
    Chemotherapy; 1986; 32(5):399-403. PubMed ID: 3757585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone effect on bilirubin-albumin binding.
    Fink S; Karp W; Robertson A
    Pediatrics; 1987 Dec; 80(6):873-5. PubMed ID: 3684399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable in vivo binding of valproic acid in epilepsy patients being medicated with other anticonvulsants.
    Haidukewych D; Rodin EA
    Clin Chem; 1980 Oct; 26(11):1634-5. PubMed ID: 6774840
    [No Abstract]   [Full Text] [Related]  

  • 6. Competition between valproate & phenytoin for plasma protein binding.
    Jaffery NF; Ahmad SN; Jailkhani BL
    Indian J Med Res; 1986 Apr; 83():426-8. PubMed ID: 3087873
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum protein binding of valproic acid and its displacement by palmitic acid in vitro.
    Monks A; Richens A
    Br J Clin Pharmacol; 1979 Aug; 8(2):187-9. PubMed ID: 385026
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum protein binding of diazepam and its displacement by valproic acid in vitro.
    Dhillon S; Richens A
    Br J Clin Pharmacol; 1981 Oct; 12(4):591-2. PubMed ID: 6794588
    [No Abstract]   [Full Text] [Related]  

  • 9. Uremic sera contain inhibitors that block digitoxin-valproic acid interaction.
    Dasgupta A; Paul A; Wells A
    Am J Med Sci; 2001 Oct; 322(4):204-8. PubMed ID: 11678517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of free valproic acid concentrations using the Amicon Micropartition MPS-1 Ultrafiltration System.
    March C; Blanke RV
    Ther Drug Monit; 1985; 7(1):115-20. PubMed ID: 3922094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of drugs to human serum albumin. XIV. The theoretical basis for the interaction between phenytoin and valproate.
    Kober A; Olsson Y; Sjöholm I
    Mol Pharmacol; 1980 Sep; 18(2):237-42. PubMed ID: 6775182
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum protein binding of valproic acid in healthy subjects and in patients with liver disease.
    Urien S; Albengres E; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):319-25. PubMed ID: 6790449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fatty acids on serum binding between furosemide and valproic acid.
    Takamura N; Shinozawa S; Maruyama T; Suenaga A; Otagiri M
    Biol Pharm Bull; 1998 Feb; 21(2):174-6. PubMed ID: 9514615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic determination of the binding of ceftriaxone to human serum albumin solution and albumin from diluted human serum.
    Mohler J; Meulemans A; Vulpillat M
    J Chromatogr; 1990 Jun; 528(2):415-23. PubMed ID: 2384579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Displacement effect of valproate on bilirubin-albumin binding in human plasma.
    Yu HY; Shen YZ
    J Formos Med Assoc; 1999 Mar; 98(3):201-4. PubMed ID: 10365540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting ceftriaxone plasma protein binding during open heart surgery.
    Jungbluth GL; Pasko MT; Jusko WJ
    J Pharm Sci; 1989 Oct; 78(10):807-11. PubMed ID: 2600784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced in vitro displacement of valproic acid from protein binding by salicylate in uremic sera compared with normal sera. Role of uremic compounds.
    Dasgupta A; Jacques M
    Am J Clin Pathol; 1994 Mar; 101(3):349-53. PubMed ID: 8135194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished protein binding capacity of uremic sera for valproate following hemodialysis: role of free fatty acids and uremic compounds.
    Dasgupta A; Jacques M; Malhotra D
    Am J Nephrol; 1996; 16(4):327-33. PubMed ID: 8739287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equilibrium dialysis, ultrafiltration, and ultracentrifugation compared for determining the plasma-protein-binding characteristics of valproic acid.
    Barré J; Chamouard JM; Houin G; Tillement JP
    Clin Chem; 1985 Jan; 31(1):60-4. PubMed ID: 3917383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma protein binding interaction between phenytoin and valproic acid in vitro.
    Monks A; Boobis S; Wadsworth J; Richens A
    Br J Clin Pharmacol; 1978 Dec; 6(6):487-92. PubMed ID: 365209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.